290 related articles for article (PubMed ID: 21733570)
1. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.
Vaglio A; Palmisano A; Alberici F; Maggiore U; Ferretti S; Cobelli R; Ferrozzi F; Corradi D; Salvarani C; Buzio C
Lancet; 2011 Jul; 378(9788):338-46. PubMed ID: 21733570
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.
Alberici F; Palmisano A; Urban ML; Maritati F; Oliva E; Manenti L; Ferretti S; Cobelli R; Buzio C; Vaglio A
Ann Rheum Dis; 2013 Sep; 72(9):1584-6. PubMed ID: 23696631
[No Abstract] [Full Text] [Related]
3. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
4. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial.
Kazui H; Miyajima M; Mori E; Ishikawa M;
Lancet Neurol; 2015 Jun; 14(6):585-94. PubMed ID: 25934242
[TBL] [Abstract][Full Text] [Related]
5. [Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis].
de Beus E; Rensma PL
Ned Tijdschr Geneeskd; 2007 Jan; 151(3):161-6. PubMed ID: 17288338
[TBL] [Abstract][Full Text] [Related]
6. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P; Maho-Vaillant M; Prost-Squarcioni C; Hebert V; Houivet E; Calbo S; Caillot F; Golinski ML; Labeille B; Picard-Dahan C; Paul C; Richard MA; Bouaziz JD; Duvert-Lehembre S; Bernard P; Caux F; Alexandre M; Ingen-Housz-Oro S; Vabres P; Delaporte E; Quereux G; Dupuy A; Debarbieux S; Avenel-Audran M; D'Incan M; Bedane C; Bénéton N; Jullien D; Dupin N; Misery L; Machet L; Beylot-Barry M; Dereure O; Sassolas B; Vermeulin T; Benichou J; Musette P;
Lancet; 2017 May; 389(10083):2031-2040. PubMed ID: 28342637
[TBL] [Abstract][Full Text] [Related]
7. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
[TBL] [Abstract][Full Text] [Related]
8. Remission of idiopathic retroperitoneal fibrosis after sequential therapy with corticosteroids and tamoxifen.
Tan MO; Uygur MC; Diker Y; Erol D
Urol Int; 2003; 71(4):426-9. PubMed ID: 14646446
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Mateos MV; Oriol A; Martínez-López J; Gutiérrez N; Teruel AI; de Paz R; García-Laraña J; Bengoechea E; Martín A; Mediavilla JD; Palomera L; de Arriba F; González Y; Hernández JM; Sureda A; Bello JL; Bargay J; Peñalver FJ; Ribera JM; Martín-Mateos ML; García-Sanz R; Cibeira MT; Ramos ML; Vidriales MB; Paiva B; Montalbán MA; Lahuerta JJ; Bladé J; Miguel JF
Lancet Oncol; 2010 Oct; 11(10):934-41. PubMed ID: 20739218
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis.
Lee RW; Greenwood R; Taylor H; Amer R; Biester S; Heissigerova J; Forrester JV; Dick AD
Ophthalmology; 2012 Jun; 119(6):1223-30. PubMed ID: 22381809
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Masuda N; Sagara Y; Kinoshita T; Iwata H; Nakamura S; Yanagita Y; Nishimura R; Iwase H; Kamigaki S; Takei H; Noguchi S
Lancet Oncol; 2012 Apr; 13(4):345-52. PubMed ID: 22265697
[TBL] [Abstract][Full Text] [Related]
14. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.
Scheel PJ; Piccini J; Rahman MH; Lawler L; Jarrett T
J Urol; 2007 Jul; 178(1):140-3; discussion 143-4. PubMed ID: 17499287
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis.
Brandt AS; Kamper L; Kukuk S; Haage P; Roth S
Urol Int; 2014; 93(3):320-5. PubMed ID: 25073896
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.
Moroni G; Gallelli B; Banfi G; Sandri S; Messa P; Ponticelli C
Nephrol Dial Transplant; 2006 Sep; 21(9):2485-90. PubMed ID: 16702201
[TBL] [Abstract][Full Text] [Related]
17. Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.
Jin J; Wang JX; Chen FF; Wu DP; Hu J; Zhou JF; Hu JD; Wang JM; Li JY; Huang XJ; Ma J; Ji CY; Xu XP; Yu K; Ren HY; Zhou YH; Tong Y; Lou YJ; Ni WM; Tong HY; Wang HF; Mi YC; Du X; Chen BA; Shen Y; Chen Z; Chen SJ
Lancet Oncol; 2013 Jun; 14(7):599-608. PubMed ID: 23664707
[TBL] [Abstract][Full Text] [Related]
18. [Regression of retroperitoneal fibrosis treated by tamoxifen].
Devevey JM; Michel F; Chevet D; Rifle G; Arnould L
Prog Urol; 1996; 6(4):578-81. PubMed ID: 8924937
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse.
Raffiotta F; da Silva Escoli R; Quaglini S; Rognoni C; Sacchi L; Binda V; Messa P; Moroni G
Am J Kidney Dis; 2019 Dec; 74(6):742-750. PubMed ID: 31204195
[TBL] [Abstract][Full Text] [Related]
20. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
